NeuroOne Medical Technologies Corporation
General ticker "NMTC" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $36.9M (TTM average)
NeuroOne Medical Technologies Corporation does not follow the US Stock Market performance with the rate: -34.9%.
Estimated limits based on current volatility of 3.0%: low 1.01$, high 1.07$
Factors to consider:
- Total employees count: 18 (+5.9%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Operating losses, Profitability, Capital raising, Regulatory and compliance, Market acceptance
- Current price 67.4% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [3.26$, 8.50$]
- 2026-09-30 to 2027-09-30 estimated range: [2.95$, 7.83$]
Financial Metrics affecting the NMTC estimates:
- Positive: with PPE of -10.2 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: 58.56 < Shareholder equity ratio, % of 65.57 <= 69.38
- Positive: -51.61 < Industry operating profit margin (median), % of -34.01
- Positive: -1.23 < Investing cash flow per share per price, % of -0.22
- Positive: Industry inventory ratio change (median), % of -0.68 <= -0.33
Short-term NMTC quotes
Long-term NMTC plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $3.41MM | $3.45MM | $12.10MM |
| Operating Expenses | $15.36MM | $15.34MM | $16.32MM |
| Operating Income | $-11.96MM | $-11.89MM | $-4.23MM |
| Non-Operating Income | $0.10MM | $-0.43MM | $0.62MM |
| Interest Expense | $0.00MM | $0.23MM | $0.33MM |
| R&D Expense | $6.94MM | $5.07MM | $4.98MM |
| Income(Loss) | $-11.86MM | $-12.32MM | $-3.61MM |
| Net Income(Loss)* | $-11.86MM | $-12.32MM | $-3.61MM |
| Stockholders Equity | $6.25MM | $0.82MM | $7.07MM |
| Inventory | $1.73MM | $2.64MM | $2.23MM |
| Assets | $8.10MM | $5.37MM | $10.79MM |
| Operating Cash Flow | $-12.89MM | $-11.01MM | $-2.84MM |
| Capital expenditure | $0.38MM | $0.12MM | $0.08MM |
| Investing Cash Flow | $2.65MM | $-0.12MM | $-0.08MM |
| Financing Cash Flow | $7.40MM | $7.27MM | $8.03MM |
| Earnings Per Share** | $-3.93 | $-2.76 | $-0.54 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.